X

Trial Profile

A Two-part Study To Assess the Safety and Preliminary Efficacy of Givinostat in Patients With JAK2V617F Positive Polycythemia Vera

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 21 Dec 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Givinostat (Primary)
Indications Polycythaemia vera
Focus Adverse reactions; Therapeutic Use
Sponsors Italfarmaco

Most Recent Events

20 Dec 2021 This trial has been completed in Hungary, according to European Clinical Trials Database
16 Dec 2021 This trial has been completed in France, according to European Clinical Trials Database.
14 Feb 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com